Stem Cell Therapy For Parkinson's


Stem Cell Therapy For Parkinson's

Parkinson's disease is a chronic and progressive neurological disorder that affects movement. Parkinson's disease is one of the most common neurodegenerative disorders in the world.

Key features of Parkinson's disease include:

1.    Motor symptoms: The primary symptoms of Parkinson's disease are related to movement difficulties. These may include tremors  at rest, rigidity  of muscles,  slowness of movement and balance problems.

2.    Non-motor symptoms: Parkinson's disease can also cause a range of non-motor symptoms, such as cognitive changes problems with memory and thinking, mood changes, sleep disturbances, and autonomic dysfunction  changes in blood pressure and digestion.

3.    Substantia nigra degeneration: Parkinson's disease is associated with the degeneration of dopamine-producing neurons in a region of the brain called the substantia nigra. The loss of dopamine leads to the motor symptoms characteristic of the disease.

4.    Age of onset: Parkinson's disease typically develops in individuals over the age of 60, though it can occur earlier in some cases .

5.    Diagnosis and management: There is no definitive test for Parkinson's disease, and diagnosis is primarily based on clinical assessment by a healthcare professional. While there is no cure for Parkinson's, various treatments, including medication, physical therapy, and sometimes surgery, can help manage symptoms and improve quality of life.

What may this include:

  • Medical Consultation
  • 200 million MSCs
  • Exosomes 30 MC (amount is determined by our doctors depending on age/weight ).
  • Multivitamins. All administered by IV.
  • Treatment is done in two visits:
  • Post therapy diet
 * Treatment is done in two visits:


1. Lindvall O, Barker RA, Brüstle O, et al. Clinical translation of stem cells in neurodegenerative disorders. Cell Stem Cell. 2012;10(2):151-5. doi: 10.1016/j.stem.2012.01.007.

2. Barker RA, Drouin-Ouellet J, Parmar M. Cell-based therapies for Parkinson disease—past insights and future potential. Nat Rev Neurol. 2015;11(9):492-503. doi: 10.1038/nrneurol.2015.123.

3. Mendonça L, Nóbrega C, Hirai H, et al. Transplantation of cryopreserved human embryonic stem cells-derived neuronal precursors in a rat model of Parkinson's disease. J Vis Exp. 2014;(89):e51409. doi: 10.3791/51409.